Home LiteratureArticle Details
PMID: 20948989 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.

Oncotarget ·Vol. 1 ·No. 5 ·2010-09-00 ·Pages 349-58

Noonan EJ, Place RF, Basak S, Pookot D, Li LC

Abstract

MicroRNAs (miRNAs) are a class of small non-coding RNAs (ncRNAs) that regulate gene expression by repressing translation or triggering the degradation of complementary mRNA sequences. Certain miRNAs have been shown to function as integral components of the p53 and/or retinoblastoma (Rb) regulatory networks. As such, miRNA dysregulation can have a profound effect on cancer development. Previous studies have shown that miR-449a is down-regulated in human prostate cancer tissue and possesses potential tumor suppressor function. In the present study, we identify miR-449a-mediated growth arrest in prostate cancer cells is dependent on the Rb protein. We show that mutant Rb prostate cancer cells (DU- 145) are resistant to cell cycle arrest and cellular senescence induced by miR- 449a, while overexpression of wild-type Rb in DU-145 sublines (DU-1.1 and B5) restores miR-449a function. In silico analysis of 3'UTR regions reveal a putative miR-449a target site in the transcript of Cyclin D1 (CCND1); an oncogene involved in directly regulating Rb activity and cell cycle progression. Luciferase 3'UTR reporter constructs and inhibitory oligonucleotides confirm that Cyclin D1 is a direct downstream target of miR-449a. We also reveal that miR-449a suppresses Rb phosphorylation through the knockdown of Cyclin D1 and previously validated target HDAC1. By targeting genes involved in controlling Rb activity, miR- 449a regulates growth and senescence in an Rb-dependent manner. These data indicate that miR-449a is a miRNA component of the Rb pathway and its tumor suppressor-like effects, in part, depends on Rb status in prostate cancer cells.

Keywords
CCND1 HDAC1 Prostate cancer cell cycle cellular senescence miR-449a miRNA p27 retinoblastoma
MeSH Terms
3' Untranslated Regions Apoptosis Binding Sites Cell Cycle Cell Line, Tumor Cell Proliferation Cellular Senescence Cyclin D1/genetics,metabolism Gene Expression Regulation, Neoplastic Genes, Reporter Histone Deacetylase 1/genetics,metabolism Humans Male MicroRNAs/metabolism Mutation Phosphorylation Prostatic Neoplasms/genetics,metabolism,pathology RNA Interference Retinoblastoma Protein/genetics,metabolism Transfection
Chemicals
3' Untranslated Regions CCND1 protein, human MIRN449 microRNA, human MicroRNAs Retinoblastoma Protein Cyclin D1 HDAC1 protein, human Histone Deacetylase 1
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Noonan Emily J
Center for Molecular Biology in Medicine, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA. Emily.Noonan@gmail.com
Place Robert F
Basak Shashwati
Pookot Deepa
Li Long-Cheng
References (37)
37 references, click to expand
  1. Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma.
    Am J Respir Cell Mol Biol. 2001 Nov;25(5):562-8 PMID: 11713097
  2. miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A.
    Genes Dev. 2009 Oct 15;23(20):2388-93 PMID: 19833767
  3. Conditional deletion of Rb causes early stage prostate cancer.
    Cancer Res. 2004 Sep 1;64(17):6018-25 PMID: 15342382
  4. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.
    Cell Cycle. 2007 Jul 1;6(13):1586-93 PMID: 17554199
  5. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone.
    Clin Cancer Res. 2000 May;6(5):1891-5 PMID: 10815912
  6. Minireview: Cyclin D1: normal and abnormal functions.
    Endocrinology. 2004 Dec;145(12):5439-47 PMID: 15331580
  7. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.
    Oncogene. 1999 May 6;18(18):2789-97 PMID: 10362249
  8. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.
    Oncogene. 2009 Apr 9;28(14):1714-24 PMID: 19252524
  9. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts.
    Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13742-7 PMID: 8943005
  10. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.
    Mol Cell Biol. 1998 Feb;18(2):753-61 PMID: 9447971
  11. Repression of protein synthesis by miRNAs: how many mechanisms?
    Trends Cell Biol. 2007 Mar;17(3):118-26 PMID: 17197185
  12. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms.
    Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9779-84 PMID: 12902540
  13. Molecular characterization of human prostate carcinoma cell lines.
    Prostate. 2003 Nov 1;57(3):205-25 PMID: 14518029
  14. Aberrant regulation of survivin by the RB/E2F family of proteins.
    J Biol Chem. 2004 Sep 24;279(39):40511-20 PMID: 15271987
  15. Rb function in cell-cycle regulation and apoptosis.
    Nat Cell Biol. 2000 Apr;2(4):E65-7 PMID: 10783254
  16. 5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines.
    Genes Chromosomes Cancer. 2001 Feb;30(2):187-95 PMID: 11135436
  17. Human MicroRNA targets.
    PLoS Biol. 2004 Nov;2(11):e363 PMID: 15502875
  18. Radiation-induced apoptosis mediated by retinoblastoma protein.
    Cancer Res. 1998 Aug 1;58(15):3275-81 PMID: 9699655
  19. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
    Mol Cell. 2007 Jun 8;26(5):745-52 PMID: 17540599
  20. Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization.
    Cell Cycle. 2002 Nov-Dec;1(6):394-400 PMID: 12548012
  21. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.
    Science. 1990 Feb 9;247(4943):712-5 PMID: 2300823
  22. Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.
    Br J Cancer. 1994 Dec;70(6):1252-7 PMID: 7526887
  23. Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.
    J Urol. 2005 Feb;173(2):342-59 PMID: 15643172
  24. E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis.
    Cell Death Differ. 2010 Mar;17(3):452-8 PMID: 19960022
  25. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications.
    J Clin Invest. 2007 Aug;117(8):2059-66 PMID: 17671640
  26. Role of microRNAs in plant and animal development.
    Science. 2003 Jul 18;301(5631):336-8 PMID: 12869753
  27. miR-449 regulates CDK-Rb-E2F1 through an auto-regulatory feedback circuit.
    Cell Cycle. 2010 Jan 15;9(2):213-4 PMID: 20046097
  28. A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
    Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7 PMID: 7568133
  29. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors.
    Prostate. 1998 May;35(2):95-101 PMID: 9568672
  30. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.
    Cancer Res. 1999 Jun 15;59(12):2957-64 PMID: 10383161
  31. HDACs and the senescent phenotype of WI-38 cells.
    BMC Cell Biol. 2005 Oct 26;6:37 PMID: 16250917
  32. Molecular analysis of multifocal prostate cancer lesions.
    J Pathol. 1999 Jul;188(3):271-7 PMID: 10419595
  33. Histone deacetylase inhibitors: molecular mechanisms of action.
    Oncogene. 2007 Aug 13;26(37):5541-52 PMID: 17694093
  34. A microRNA component of the p53 tumour suppressor network.
    Nature. 2007 Jun 28;447(7148):1130-4 PMID: 17554337
  35. Genome-wide scan of Swedish families with hereditary prostate cancer: suggestive evidence of linkage at 5q11.2 and 19p13.3.
    Prostate. 2003 Dec 1;57(4):290-7 PMID: 14601025
  36. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
    Cancer Lett. 2009 Mar 8;275(1):44-53 PMID: 19006648
  37. The MYCN oncogene is a direct target of miR-34a.
    Oncogene. 2008 Sep 4;27(39):5204-13 PMID: 18504438
Article Info
Journal
Oncotarget
Abbr.
Oncotarget
ISSN
1949-2553
Published
2010-09-00
Pages
349-58
Language
English
Region
United States
NLM ID
101532965
PMCID
PMC2952964
Subset
IM
Grants
NCI NIH HHS · P50 CA089520 · United States
NCI NIH HHS · P50 CA089520-05 · United States
NCI NIH HHS · P50CA89520 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com